Authors:
Stein, CS
Kang, Y
Sauter, SL
Townsend, K
Staber, P
Derksen, TA
Martins, I
Qian, J
Davidson, BL
McCray, PB
Citation: Cs. Stein et al., In vivo treatment of hemophilia A and mucopolysaccharidosis type VII usingnonprimate lentiviral vectors, MOL THER, 3(6), 2001, pp. 850-856
Authors:
DePolo, NJ
Reed, JD
Sheridan, PL
Townsend, K
Sauter, SL
Jolly, DJ
Dubensky, TW
Citation: Nj. Depolo et al., VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum, MOL THER, 2(3), 2000, pp. 218-222
Authors:
Sheridan, PL
Bodner, M
Lynn, A
Phuong, TK
DePolo, NJ
de la Vega, DJ
O'Dea, J
Nguyen, K
McCormack, JE
Driver, DA
Townsend, K
Ibanez, CE
Sajjadi, NC
Greengard, JS
Moore, MD
Respess, J
Chang, SMW
Dubensky, TW
Jolly, DJ
Sauter, SL
Citation: Pl. Sheridan et al., Generation of retroviral packaging and producer cell lines for large-scalevector production and clinical application: Improved safety and high titer, MOL THER, 2(3), 2000, pp. 262-275
Authors:
Polo, JM
Belli, BA
Driver, DA
Frolov, I
Sherrill, S
Hariharan, MJ
Townsend, K
Perri, S
Mento, SJ
Jolly, DJ
Chang, SMW
Schlesinger, S
Dubensky, TW
Citation: Jm. Polo et al., Stable alphavirus packaging cell lines for Sindbis virus- and Semliki Forest virus-derived vectors, P NAS US, 96(8), 1999, pp. 4598-4603